73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Cancers in distant organs alter liver function, shows study

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules

Cancers in distant organs alter liver function, shows study

by Jim Schnabel,Cornell UniversityRemote primary tumors induce metabolic dysfunction in the liver. Credit:Nature(2023). DOI: 10.1038/s41586-023-06114-4Cancers often release molecules
Leveraging the power of iPS cell technology to study myeloid neoplasm

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea
Surveillance colonoscopy rarely IDs cancer in older adults, study finds

Surveillance colonoscopy rarely IDs cancer in older adults, study finds

by Lori SolomonColorectal cancer (CRC) is rarely detected from surveillance colonoscopy among older adults, regardless of prior adenoma findings, according to astudypublished online April

Surveillance colonoscopy rarely IDs cancer in older adults, study finds

by Lori SolomonColorectal cancer (CRC) is rarely detected from surveillance colonoscopy among older adults, regardless of prior adenoma findings, according to astudypublished online April
Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor
Shedding light—literally—on resistance to radiation therapy

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether
Study confirms pancreatic cancer rates rising faster in women than men

Study confirms pancreatic cancer rates rising faster in women than men

by Cedars-Sinai Medical CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainIn a large-scale nationwide study, investigators from Ceda

Study confirms pancreatic cancer rates rising faster in women than men

by Cedars-Sinai Medical CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainIn a large-scale nationwide study, investigators from Ceda
Investigating mechanisms of aggressive glioblastoma tumor growth

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr
International team discovers unique pathway for treating deadly children's brain cancer

International team discovers unique pathway for treating deadly children's brain cancer

by Steve Yozwiak,The Translational Genomics Research InstituteCredit: CC0 Public DomainAn international team of researchers led by Yale University, University of Iowa, and the Translational Geno

International team discovers unique pathway for treating deadly children's brain cancer

by Steve Yozwiak,The Translational Genomics Research InstituteCredit: CC0 Public DomainAn international team of researchers led by Yale University, University of Iowa, and the Translational Geno
New drug delays progression of glioma, a deadly brain cancer, during clinical trial

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Research is uncovering new ways to treat an aggressive brain cancer

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re
Immunotherapy comparable to chemo for some advanced stomach cancers

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food

Immunotherapy comparable to chemo for some advanced stomach cancers

by Cancer Research UKCredit: CC0 Public DomainAn immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food